FORM 8-K

Company

Lexaria Bioscience Corp.

Filed

August 28, 2023

Period of Report

August 24, 2023

Accession Number

0001640334-23-001644

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →